Cargando…
Synthetic Melanin Acts as Efficient Peptide Carrier in Cancer Vaccine Strategy
We previously reported that a novel peptide vaccine platform, based on synthetic melanin nanoaggregates, triggers strong cytotoxic immune responses and significantly suppresses tumor growth in mice. However, the mechanisms underlying such an efficacy remained poorly described. Herein, we investigate...
Autores principales: | Cuzzubbo, Stefania, Roch, Benoit, Darrasse-Jèze, Guillaume, Hosten, Benoit, Leclercq, Manon, Vignal, Nicolas, Banissi, Claire, Tartour, Eric, Carpentier, Antoine F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738778/ https://www.ncbi.nlm.nih.gov/pubmed/36499300 http://dx.doi.org/10.3390/ijms232314975 |
Ejemplares similares
-
Synthetic melanin bound to subunit vaccine antigens significantly enhances CD8(+) T-cell responses
por: Carpentier, Antoine F., et al.
Publicado: (2017) -
Applications of Melanin and Melanin-Like Nanoparticles in Cancer Therapy: A Review of Recent Advances
por: Cuzzubbo, Stefania, et al.
Publicado: (2021) -
How Numbers, Nature, and Immune Status of Foxp3(+) Regulatory T-Cells Shape the Early Immunological Events in Tumor Development
por: Darrasse-Jèze, Guillaume, et al.
Publicado: (2013) -
Continuous Activation of Autoreactive CD4(+) CD25(+) Regulatory T Cells in the Steady State
por: Fisson, Sylvain, et al.
Publicado: (2003) -
Iron Oxide Nanoparticles Coated with a Phosphorothioate Oligonucleotide and a Cationic Peptide: Exploring Four Different Ways of Surface Functionalization
por: Geinguenaud, Frédéric, et al.
Publicado: (2015)